Publications by authors named "Laure-Anne Teuwen"

Claim this Profile
O
Overall survival assessment in cancer drug trials: a luxury or a necessity?
Samuel X Stevens, Laure-Anne Teuwen, Bishal Gyawali

Lancet Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.
Sofie Seghers, Pablo Mandó, Marc Eid, Charles J Tan, Aarthi Jayraj, Laure-Anne Teuwen

JCO Oncol Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferior control arms in oncology trials in LMICs: contextualised or compromised?
Laure-Anne Teuwen, Bishal Gyawali

BMJ Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Success in oncology phase 3 trials: a small P value or patient value.
Laure-Anne Teuwen, Gregory R Pond, Bishal Gyawali

J Natl Cancer Inst· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Fear of Cancer Recurrence with Internet-Based Emotional Freedom Techniques (iEFT) and Mindfulness Meditation Intervention (iMMI) (BGOG-gyn1b/REMOTE).
Laura Tack, Lore Mertens, Marte Vandeweyer, Fien Florin, Emma Pauwels, Laure-Anne Teuwen

Brain Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is switching to T-DM1 still justified in HER2-negative residual breast cancer after neoadjuvant systemic therapy?
Wiebren Tjalma, Laure-Anne Teuwen, Sevilay Altintas, Konstantinos Papadimitriou

Breast· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endo- and myocarditis as a severe complication of immune-related adverse event treatment: a case report.
Lauren Van den Bosch, PieterJan Vanclooster, Jan Van Offenwert, Laure-Anne Teuwen, Constantijn Franssen

Eur Heart J Case Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of SERPINA3 in response to anthracycline treatment and cardiovascular dysfunction.
Hanne M Boen, Lobke L Pype, Konstantinos Papadimitriou, Sevilay Altintas, Laure-Anne Teuwen

Cardiooncology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022.
Laure-Anne Teuwen, Joanna Young, Saleh Alessy, Berna C Özdemir, Diah Martina

JCO Glob Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1a/1b Study of Fostroxacitabine Bralpamide (Fostrox) Monotherapy in Hepatocellular Carcinoma and Solid Tumor Liver Metastases.
Ruth Plummer, Alastair Greystoke, Gregory Naylor, Debashis Sarker, A N M Kaiser Anam, Laure-Anne Teuwen

J Hepatocell Carcinoma· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to Update-Requesting Inclusive Submission Categories for Oncology Research.
Laure-Anne Teuwen, Zain Ahmad, Eva Segelov

JCO Glob Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study.
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen

JCO Glob Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrity matters in oncology: AORTIC takes a stand against research misconduct.
Khalid El Bairi, Dario Trapani, Laure-Anne Teuwen, Belmira Rodrigues, Miriam Mutebi

BJC Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel therapeutic strategies in pancreatic cancer: moving beyond cytotoxic chemotherapy.
Barbara Geerinckx, Laure-Anne Teuwen, Tiffany Foo, Timon Vandamme, Annabel Smith

Expert Rev Anticancer Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Immunotherapy in Esophageal and Gastric Cancer.
Hans Dedecker, Laure-Anne Teuwen, Timon Vandamme, Andreas Domen, Hans Prenen

Clin Colorectal Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate hypersensitivity reactions to antineoplastic agents - A practical guide for the oncologist.
Sofie Seghers, Laure-Anne Teuwen, Michiel Beyens, Dennis De Blick, Vito Sabato

Cancer Treat Rev· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling and Therapeutic Implications for Patients with Advanced Cancers: The Experience of an Academic Hospital.
Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen

Diagnostics (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution.
Laura P M H de Rooij, Lisa M Becker, Laure-Anne Teuwen, Bram Boeckx, Sander Jansen

Cardiovasc Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.
Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Angelina Konnova, Fien H R De Winter, Akshita Gupta, Lise Verbruggen, An Hotterbeekx, Laure-Anne Teuwen

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
Johannes Robert Fleischer, Alexandra Maria Schmitt, Gwendolyn Haas, Xingbo Xu, Elisabeth Maria Zeisberg, Laure-Anne Teuwen

Mol Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells.
Anne Cuypers, Laure-Anne Teuwen, Victoria L Bridgeman, Laura P M H de Rooij, Guy Eelen

STAR Protoc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast.
Vincent Geldhof, Laura P M H de Rooij, Liliana Sokol, Jacob Amersfoort, Maxim De Schepper, Laure-Anne Teuwen

Nat Commun· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocols for endothelial cell isolation from mouse tissues: kidney, spleen, and testis.
Sébastien J Dumas, Elda Meta, Nadine V Conchinha, Liliana Sokol, Rongyuan Chen, Laure-Anne Teuwen

STAR Protoc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocols for endothelial cell isolation from mouse tissues: brain, choroid, lung, and muscle.
Nadine V Conchinha, Liliana Sokol, Laure-Anne Teuwen, Koen Veys, Sébastien J Dumas

STAR Protoc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis